HomeCompareCAH vs SNPS

CAH vs SNPS: Dividend Comparison 2026

CAH yields 0.99% · SNPS yields 0.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CAH wins by $1.2K in total portfolio value
10 years
CAH
CAH
● Live price
0.99%
Share price
$206.31
Annual div
$2.04
5Y div CAGR
5.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.6K
Annual income
$185.04
Full CAH calculator →
SNPS
SNPS
● Live price
0.52%
Share price
$383.14
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.4K
Annual income
$54.00
Full SNPS calculator →

Portfolio growth — CAH vs SNPS

📍 CAH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCAHSNPS
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CAH + SNPS cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CAH pays
SNPS pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CAH
Annual income on $10K today (after 15% tax)
$83.95/yr
After 10yr DRIP, annual income (after tax)
$157.28/yr
SNPS
Annual income on $10K today (after 15% tax)
$44.37/yr
After 10yr DRIP, annual income (after tax)
$45.90/yr
At 15% tax rate, CAH beats the other by $111.38/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CAH + SNPS for your $10,000?

CAH: 50%SNPS: 50%
100% SNPS50/50100% CAH
Portfolio after 10yr
$21.0K
Annual income
$119.52/yr
Blended yield
0.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SNPS right now

CAH
Analyst Ratings
18
Buy
15
Hold
Consensus: Buy
Price Target
$252.33
+22.3% upside vs current
Range: $220.00 — $275.00
Altman Z
4.8
Piotroski
5/9
SNPS
Analyst Ratings
22
Buy
5
Hold
Consensus: Buy
Price Target
$528.75
+38.0% upside vs current
Range: $425.00 — $600.00
Altman Z
3.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CAH buys
0
SNPS buys
0
No recent congressional trades found for CAH or SNPS in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCAHSNPS
Forward yield0.99%0.52%
Annual dividend / share$2.04$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR5.6%0%
Portfolio after 10y$21.6K$20.4K
Annual income after 10y$185.04$54.00
Total dividends collected$1.4K$532.00
Payment frequencyquarterlyquarterly
SectorHealthcareTechnology
Analyst consensusBuyBuy
Analyst price target$252.33$528.75

Year-by-year: CAH vs SNPS ($10,000, DRIP)

YearCAH PortfolioCAH Income/yrSNPS PortfolioSNPS Income/yrGap
1← crossover$10,804$104.30$10,752$52.20+$52.00CAH
2$11,672$111.21$11,557$52.45+$115.00CAH
3$12,607$118.57$12,419$52.69+$188.00CAH
4$13,616$126.40$13,341$52.92+$275.00CAH
5$14,704$134.73$14,328$53.13+$376.00CAH
6$15,877$143.59$15,385$53.33+$492.00CAH
7$17,142$153.02$16,515$53.51+$627.00CAH
8$18,504$163.04$17,725$53.69+$779.00CAH
9$19,973$173.70$19,019$53.85+$954.00CAH
10$21,557$185.04$20,405$54.00+$1.2KCAH

CAH vs SNPS: Complete Analysis 2026

CAHHealthcare

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Full CAH Calculator →

SNPSTechnology

Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company offers Fusion Design Platform that provides digital design implementation solutions; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. It also provides intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, SATA, MIPI, HDMI, and Bluetooth low energy applications; analog IP, including data converters and audio codecs; and system-on-chip (SoC) infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating-point components, and Arm AMBA interconnect fabric and peripherals. In addition, the company offers logic libraries and embedded memories; configurable processor cores and application-specific instruction-set processor tools for embedded applications; IP subsystems for audio, sensor, and data fusion functionality; and security IP solutions. Further, it provides Platform Architect solutions for SoC architecture analysis and optimization; virtual prototyping solutions; and HAPS FPGA-based prototyping systems, as well as a series of tools used in the design of optical systems and photonic devices. Additionally, the company offers security testing, managed services, programs and professional services, and training that enable its customers to detect and remediate security vulnerabilities, and defects in the software development lifecycle, as well as manufacturing solutions. It serves electronics, financial services, automotive, medicine, energy, and industrial areas. The company was incorporated in 1986 and is headquartered in Mountain View, California.

Full SNPS Calculator →
📬

Get this CAH vs SNPS comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CAH vs SCHDCAH vs JEPICAH vs OCAH vs KOCAH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.